Reduced expression of alpha-catenin, beta-catenin, and gamma-catenin is associated with high cell proliferative activity and poor differentiation in non-small cell lung cancer
Open Access
- 1 May 2001
- journal article
- Published by BMJ in Journal of Clinical Pathology
- Vol. 54 (5) , 391-395
- https://doi.org/10.1136/jcp.54.5.391
Abstract
Aims—To investigate the expression of catenins (α, β, and γ) in non-small cell lung carcinoma (NSCLC) and its relation to clinicopathological factors and prognosis. Methods—The expression of catenins was analysed immunohistochemically in 261 patients with resected NSCLC, diagnosed between 1978 and 1996 in eastern Finland. The cell proliferation index of the tumours was analysed by means of an image analyser. The staining results were compared with clinicopathological characteristics and survival. Results—Normal catenin staining was found significantly more often in adenocarcinomas than in squamous cell carcinomas or anaplastic/large cell carcinomas. Reduced staining of α-catenin, β-catenin, and γ-catenin was related to poor differentiation of the tumour. The tumours with reduced staining of β-catenin or γ-catenin often had higher cell proliferation activity. Nuclear staining of β-catenin and γ-catenin was found in 16 (7%) and 29 (13%) cases, respectively. This nuclear staining correlated directly with increased cell proliferation and inversely with membranous staining. In survival analyses the predictors of overall and disease free survival were stage and tumour type. The expression of catenins did not affect survival. Conclusions—The expression of α-catenin, β-catenin, and γ-catenin is related to histological type and differentiation in NSCLC, although catenins have no independent prognostic value. However, this study supports the important role of the nuclear accumulation of β-catenin and γ-catenin in highly proliferative cells.Keywords
This publication has 35 references indexed in Scilit:
- Nuclear beta catenin expression is related to unfavourable outcome in oropharyngeal and hypopharyngeal squamous cell carcinomaJournal of Clinical Pathology, 2001
- The Cadherin-Catenin System: Implications for Growth and Differentiation of Endocrine TissuesEndocrine Reviews, 1999
- The expression of beta-catenin in non-small-cell lung cancer: a clinicopathological study.Journal of Clinical Pathology, 1998
- ALTERED gamma-CATENIN EXPRESSION CORRELATES WITH POOR SURVIVAL IN PATIENTS WITH BLADDER CANCERJournal of Urology, 1998
- Predictive value of nuclear betacatenin expression for the occurrence of distant metastases in rectal cancerDiseases of the Colon & Rectum, 1998
- Expression of e-cadherin, α-catenin, β-catenin, and CD44 (standard and variant isoforms) in human cholangiocarcinoma: An immunohistochemical studyHepatology, 1998
- Nuclear Overexpression of the Oncoprotein β-Catenin in Colorectal Cancer is Localized Predominantly at the Invasion FrontPathology - Research and Practice, 1998
- Cadherin and catenin biology represent a global mechanism for epithelial cancer progression.Molecular Pathology, 1997
- Expression of E-Cadherin, α-Catenin, β-Catenin and Plakoglobin in Esophageal Carcinomas and Its Prognostic SignificanceOncology, 1997
- Expression of β‐catenin in normal breast tissue and breast carcinoma: a comparative study with epithelial cadherin and α‐cateninHistopathology, 1996